Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126235111 | 12623511 | 1 | I | 201308 | 20130509 | 20160804 | 20160804 | PER | US-CELGENEUS-163-20785-13051623 | CELGENE | 60.46 | YR | F | Y | 63.56000 | KG | 20160804 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126235111 | 12623511 | 1 | PS | THALOMID | THALIDOMIDE | 1 | Oral | N | U | UNKNOWN | 20785 | 100 | MG | CAPSULES | QD | ||||
| 126235111 | 12623511 | 2 | SS | THALOMID | THALIDOMIDE | 1 | Oral | N | U | UNKNOWN | 20785 | 200 | MG | CAPSULES | |||||
| 126235111 | 12623511 | 3 | SS | THALOMID | THALIDOMIDE | 1 | Oral | N | U | UNKNOWN | 20785 | 300 | MG | CAPSULES | |||||
| 126235111 | 12623511 | 4 | SS | THALOMID | THALIDOMIDE | 1 | Oral | 200-300MG | N | U | UNKNOWN | 20785 | CAPSULES | ||||||
| 126235111 | 12623511 | 5 | SS | THALOMID | THALIDOMIDE | 1 | Oral | N | U | UNKNOWN | 20785 | 100 | MG | CAPSULES | |||||
| 126235111 | 12623511 | 6 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 7 | C | ALBUTEROL. | ALBUTEROL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 8 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 9 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 10 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 11 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 12 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 13 | C | VALIUM | DIAZEPAM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 14 | C | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 15 | C | FOSRENOL | LANTHANUM CARBONATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 16 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 17 | C | HUMALOG | INSULIN LISPRO | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 18 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 19 | C | LEVEMIR | INSULIN DETEMIR | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 20 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 21 | C | Warfarin | WARFARIN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 22 | C | Budesonide Nebulizer | BUDESONIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126235111 | 12623511 | 23 | C | Brovana Nebulizer | 2 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126235111 | 12623511 | 1 | Plasma cell myeloma |
| 126235111 | 12623511 | 6 | Product used for unknown indication |
| 126235111 | 12623511 | 7 | Product used for unknown indication |
| 126235111 | 12623511 | 8 | Product used for unknown indication |
| 126235111 | 12623511 | 9 | Product used for unknown indication |
| 126235111 | 12623511 | 10 | Product used for unknown indication |
| 126235111 | 12623511 | 11 | Product used for unknown indication |
| 126235111 | 12623511 | 12 | Product used for unknown indication |
| 126235111 | 12623511 | 13 | Product used for unknown indication |
| 126235111 | 12623511 | 14 | Product used for unknown indication |
| 126235111 | 12623511 | 15 | Product used for unknown indication |
| 126235111 | 12623511 | 16 | Product used for unknown indication |
| 126235111 | 12623511 | 17 | Product used for unknown indication |
| 126235111 | 12623511 | 18 | Product used for unknown indication |
| 126235111 | 12623511 | 19 | Product used for unknown indication |
| 126235111 | 12623511 | 20 | Product used for unknown indication |
| 126235111 | 12623511 | 21 | Product used for unknown indication |
| 126235111 | 12623511 | 22 | Product used for unknown indication |
| 126235111 | 12623511 | 23 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126235111 | 12623511 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126235111 | 12623511 | Drug ineffective | |
| 126235111 | 12623511 | Plasma cell myeloma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126235111 | 12623511 | 1 | 201301 | 0 | ||
| 126235111 | 12623511 | 2 | 201303 | 0 | ||
| 126235111 | 12623511 | 3 | 201305 | 0 | ||
| 126235111 | 12623511 | 4 | 201308 | 201404 | 0 | |
| 126235111 | 12623511 | 5 | 201405 | 20160208 | 0 |